tradmap

ICU Financials SeaStar Medical Holding Corp

5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Financial health

  • Operating income covered interest expense -392.7× in the latest year.
Revenue & net income
-$26M -$12M $1M $0 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-18393% -9146% 100% 0% 2021 2022 2023 2024 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-762% 188% 1137% 0% 2021 2022 2023 2024 2025
ROEROA
Free cash flow (CFO − capex)
$0 $1 $1 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $4M $8M 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$106M -$41M $24M $0 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $1M -$12M 95.7% -986.6% -116.6% -85.8%
2024 $135000 -$25M 100.0% -13216.3% 1137.4% -533.1% $2M
2023 $0 -$26M 189.1% -746.7% $4M $176000
2022 -$12M 58.7% -401.3% $8M $47000
2021 -$5M 163.2% -762.2% $510000

Valuation over time

How the market has priced ICU against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 380.3 760.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is ICU growing its revenue and profit?

See the revenue and net-income charts above for SeaStar Medical Holding Corp's multi-year trend.

How much debt does ICU have?

As of FY2025, SeaStar Medical Holding Corp reported — of total debt against — of cash; operating income covered interest expense -392.7×.

What is ICU's profit margin?

In FY2025, gross margin was 95.7%, operating margin -986.6%, and net margin -984.6%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.